Objectives

Three key educational needs have been identified within low-resource settings.

1) Clinicians may lack an understanding of the presenting signs and symptoms of Multiple Myeloma (MM) coupled with poor access to diagnostic and staging tests and resources.

2) Clinicians may not be aware of the appropriate diagnostics tests and treatment approach for patients with MM.

3) Clinicians may lack effective strategies and resources to provide care for Multiple Myeloma patients at advanced stages of the disease. The proposed activity will aim to reach a global (ex-US, ex-UK) audience of over 500,000 primary care and specialist HCPs, including hematologists and oncologists, with a focus on Sub-Saharan Africa and South Asia. Three key learning outcomes have been identified for the program.

As a result of this activity, learners should be able to:

1) Describe the presenting signs of MM and list some of the available investigative procedures in a local/low resource setting.

2) Explain appropriate diagnostic tests and treatment approach for patients with MM for patients in settings where ASCT is not available.

3) Select appropriate therapies for pain management and symptom control in patients with advanced Multiple Myeloma.